Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Pilot Trial of an Individualized Web-Based Condom Use Intervention

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2012 by Centre hospitalier de l'Université de Montréal (CHUM).
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Joyal Miranda, Centre hospitalier de l'Université de Montréal (CHUM)
ClinicalTrials.gov Identifier:
NCT01726153
First received: November 6, 2012
Last updated: November 9, 2012
Last verified: November 2012

November 6, 2012
November 9, 2012
November 2012
November 2013   (final data collection date for primary outcome measure)
Change from Baseline in participants self-efficacy in condom use at 2-weeks post-intervention [ Time Frame: baseline and 2-weeks post intervention ] [ Designated as safety issue: No ]
The Self-Efficacy for condom use measure contains a set of items to rate participant's belief that they will be able to use condoms every time they have anal sex in a variety of situations. A four-point response scale, ranging from 'strongly agree' (0) to 'strongly disagree' (4) is used. The psychometric properties of the measure have been examined and have been shown to have good internal consistency with Cronbach's alpha coefficient of 0.96.
Same as current
Complete list of historical versions of study NCT01726153 on ClinicalTrials.gov Archive Site
Change from Baseline in participants intention to use condoms at 2-weeks post-intervention [ Time Frame: Baseline and 2-weeks post intervention ] [ Designated as safety issue: No ]
The intention to use condoms measure asks participants their intention to consistently use condoms. The psychometric properties of the measure have been examined and have shown to have good internal consistency with Cronbach's alpha coefficient of 0.89.
Same as current
Change from Baseline in participants condom use at 2-weeks post-intervention Condom Use [ Time Frame: baseline and 2-weeks post intervention ] [ Designated as safety issue: No ]
Same as current
 
A Pilot Trial of an Individualized Web-Based Condom Use Intervention
A Pilot Randomized Control Trial (RCT) of an Individualized Condom-HIM Web-based Intervention for Condom USe Among HIV+ Gay Males

The purpose of this study is to evaluate the efficacy of an online intervention in increasing condom use among HIV+ gay males.

Not Provided
Interventional
Phase 0
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
HIV
Behavioral: Condom-HIM
The tailored on-line Condom-HIM intervention is composed of a single session involving activities to increase individuals self-efficacy and intention to use condoms.
  • No Intervention: Web sites
    Individuals assigned to this arm are given a list of websites where they can view additional information relating to condom use.
  • Experimental: Condom-HIM
    Individuals assigned to this arm must follow an on-line one session tailored intervention.
    Intervention: Behavioral: Condom-HIM
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
60
November 2013
November 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. are HIV-seropositive,
  2. Men who are having sex with men,
  3. engaging in unprotected anal intercourse with a partner who is serostatus negative or unknown
  4. age 18 years and older,
  5. ability to read English
  6. have access to a computer and internet.

Exclusion Criteria:

-

Male
18 Years and older
Yes
Contact: Joyal Miranda, PhD 416-979-5000 ext 7850 joyal.miranda@ryerson.ca
Canada
 
NCT01726153
R0018767
No
Joyal Miranda, Centre hospitalier de l'Université de Montréal (CHUM)
Centre hospitalier de l'Université de Montréal (CHUM)
Not Provided
Principal Investigator: Joyal Miranda, PhD Ryerson University and Centre hospitalier de l'Universite de Montreal (CHUM)
Centre hospitalier de l'Université de Montréal (CHUM)
November 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP